![[🔔 📊 Participate in the ENCePP Survey on AI in Pharmacoepidemiology & Pharmacovigilance]](https://cddf.org/wp-content/uploads/2026/07/Capture.jpg)
![📢 🔔 [News from EMA – Public Consultation on Its Draft Recommendations]](https://cddf.org/wp-content/uploads/2026/07/EMA-News-5-1080x675.jpg)
📢 🔔 [News from EMA – Public Consultation on Its Draft Recommendations]
The European Network of Paediatric Research at the EMA (EnprEMA) has launched a public consultation on its draft recommendations: “Cross-border access to paediatric clinical trials in Europe: preventing language exclusion.” 📄 About the draft...
🔔 Meeting of Interest in Cancer Drug Development: 2026 AAADV Workshop
Registration is NOW OPEN for the 2026 AAADV Workshop! 📅 Date: November 5–6, 2026 📍 Location: North Bethesda Marriott Hotel & Conference Center (In-Person & Virtual Participation Available) 📝 View the draft program: https://aaadv.org/2026-aaadv-workshop-agenda/...
ACT EU Multi-Stakeholder Platform: Meeting Documents from 18 June 2026
The meeting documents from ACT-EU MSP meeting held on 18 June 2026 are available now on the ACT EU website. These include presentations from the European Commission on Progress with the BioTech Act and specifically its clinical trial related aspects – present by...
Report on the ACT EU Webinar Regarding Contractual Agreements
The report on the ACT EU webinar regarding contractual agreements, held on 16 April, has been published on the ACT EU website. The webinar explored how clinical site agreements affect the start-up of clinical trials and shared national and European experiences on...